MoneyWorks4Me

USFDA completes audit at Dr. Reddy's Lab’s Srikakulam plant

29 Jan 2020 Evaluate

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy's Laboratories manufacturing plant at Srikakulam, Andhra Pradesh (CTO VI). The audit completed on January 28, 2020. After the audit, the company has been issued Form 483 with 5 observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..